Ginsenoside Rg3 Alleviates Cisplatin Resistance of Gastric Cancer Cells Through Inhibiting SOX2 and the PI3K/Akt/mTOR Signaling Axis by Up-Regulating miR-429
出版年份 2022 全文链接
标题
Ginsenoside Rg3 Alleviates Cisplatin Resistance of Gastric Cancer Cells Through Inhibiting SOX2 and the PI3K/Akt/mTOR Signaling Axis by Up-Regulating miR-429
作者
关键词
-
出版物
Frontiers in Genetics
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-03-03
DOI
10.3389/fgene.2022.823182
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Decitabine and Cisplatin are Synergistic to Exert Anti-Tumor Effect on Gastric Cancer via Inducing Sox2 DNA Demethylation
- (2021) Zhipeng Zhu et al. OncoTargets and Therapy
- SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial–mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer
- (2021) Yin Zhu et al. Cell Death & Disease
- The Efficacy of Ginsenoside Rg3 Combined with First-line Chemotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer in China: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- (2021) Ze Peng et al. Frontiers in Pharmacology
- Phytochemicals mediated modulation of microRNAs and long non‐coding RNAs in cancer prevention and therapy
- (2021) Luis M. Ruiz‐Manriquez et al. PHYTOTHERAPY RESEARCH
- Cisplatin resistance in gastric cancer cells is involved with GPR30‐mediated epithelial‐mesenchymal transition
- (2020) Xiaofeng Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- SOX2 mediates cisplatin resistance in small‐cell lung cancer with downregulated expression of hsa‐miR‐340‐5p
- (2020) Fei Cui et al. Molecular Genetics & Genomic Medicine
- Non-coding RNAs underlying chemoresistance in gastric cancer
- (2020) Arash Poursheikhani et al. CELLULAR ONCOLOGY
- PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond
- (2020) Sadegh Fattahi et al. LIFE SCIENCES
- The role and mechanisms of action of microRNAs in cancer drug resistance
- (2019) Wengong Si et al. Clinical Epigenetics
- Ginsenoside Rg3 inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT1
- (2019) Jinliang Li et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K/AKT/SOX2 axis and beyond
- (2019) Thorsten Schaefer et al. ONCOGENE
- Non-coding RNA in drug resistance of gastric cancer
- (2019) Ya-Jun Luo et al. World Journal of Gastrointestinal Oncology
- Downregulation of microRNA-17-5p inhibits drug resistance of gastric cancer cells partially through targeting p21
- (2018) Ziwei Wang et al. Oncology Letters
- Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells
- (2018) So D. Lee et al. CANCER SCIENCE
- Anticancer effects of ginsenoside Rg3 (Review)
- (2017) Mengyao Sun et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- MicroRNA‑25 contributes to cisplatin resistance in gastric cancer cells by inhibiting forkhead box O3a
- (2017) Jingbo He et al. Oncology Letters
- MiR-638 acts as a tumor suppressor gene in gastric cancer
- (2017) Yu Shen et al. Oncotarget
- Mechanisms of Resistance to Chemotherapy in Gastric Cancer
- (2016) J.J.G. Marin et al. Anti-Cancer Agents in Medicinal Chemistry
- MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1
- (2016) Yajie Zhang et al. International Journal of Biological Sciences
- Advanced gastric cancer: Current treatment landscape and future perspectives
- (2016) Antonia Digklia WORLD JOURNAL OF GASTROENTEROLOGY
- Curcumin suppresses the proliferation of gastric cancer cells by downregulating H19
- (2016) Gao Liu et al. Oncology Letters
- Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9
- (2016) Jing Wang et al. Oncotarget
- MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer
- (2016) Xiaoxiao Ge et al. Oncotarget
- Targeting SOX2 as a Therapeutic Strategy in Glioblastoma
- (2016) Laura Garros-Regulez et al. Frontiers in Oncology
- Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4
- (2015) Lili Tian et al. Oncotarget
- Sox2 is involved in paclitaxel resistance of the prostate cancer cell line PC-3 via the PI3K/Akt pathway
- (2014) DONG LI et al. Molecular Medicine Reports
- Synergistic antitumor effect of ginsenoside Rg3 and cisplatin in cisplatin-resistant bladder tumor cell line
- (2014) YOUNG JU LEE et al. ONCOLOGY REPORTS
- SOX2 promotes the migration and invasion of laryngeal cancer cells by induction of MMP-2 via the PI3K/Akt/mTOR pathway
- (2014) NING YANG et al. ONCOLOGY REPORTS
- Treatment of gastric cancer
- (2014) Michele Orditura WORLD JOURNAL OF GASTROENTEROLOGY
- The stem cell factor SOX2 regulates the tumorigenic potential in human gastric cancer cells
- (2013) Katharina Hütz et al. CARCINOGENESIS
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-κB
- (2010) Sun Mi Kim et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started